EFFICACY OF VARENICLINE, AN NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, VS PLACEBO FOR SMOKING CESSATION. A RANDOMIZED CONTROLLED TRIAL

被引：0

作者：

Wiratmoko, Mirsyam R. ^{[1
]}

Yunus, Faisal ^{[1
]}

Susanto, Agus D. ^{[1
]}

Ginting, Tribowo T. ^{[2
]}

Kekalih, Aria ^{[3
]}

机构：

[1] Univ Indonesia, Fac Med, Dept Pulmonol & Resp Med, Jakarta, Indonesia

[2] Persahabatan Hosp, Fungt Med Unit Psychiat, Jakarta, Indonesia

[3] Univ Indonesia, Fac Med, Dept Community Med, Jakarta, Indonesia

来源：

RESPIROLOGY | 2013年 / 18卷

关键词：

Varenicline; counseling; Smoking Cessation;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：66 / 66

页数：1

共 50 条

[1] Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation -: A randomized controlled trial
Jorenby, Douglas E.
Hays, J. Taylor
Rigotti, Nancy A.
Azoulay, Salomon
Watsky, Eric J.
Williams, Kathryn E.
Billing, Clare B.
Gong, Jason
Reeves, Karen R.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01): : 56 - 63
[2] Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
Gonzales, David
Rennard, Stephen I.
Nides, Mitchell
Oncken, Cheryl
Azoulay, Salomon
Billing, Clare B.
Watsky, Eric J.
Gong, Jason
Williams, Kathryn E.
Reeves, Karen R.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01): : 47 - 55
[3] Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation
Oncken, Cheryl
Gonzales, David
Nides, Mitchell
Rennard, Stephen
Watsky, Eric
Billing, Clare B.
Anziano, Richard
Reeves, Karen
[J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (15) : 1571 - 1577
[4] Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation:: A randomized controlled trial (vol 296, pg 56, 2006)
Jorenby, D. E.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (11): : 1355 - 1355
[5] A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers
Tsai, Shih-Tzu
Cho, Hong-Jun
Cheng, Huey-Shinn
Kim, Cheol-Hwan
Hsueh, Kuang-Chieh
Billing, Clare B., Jr.
Williams, Kathryn E.
[J]. CLINICAL THERAPEUTICS, 2007, 29 (06) : 1027 - 1039
[6] Dianicline, a Novel α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, for Smoking Cessation: A Randomized Placebo-Controlled Clinical Trial
Tonstad, Serena
Holme, Ingar
Tonnesen, Philip
[J]. NICOTINE & TOBACCO RESEARCH, 2011, 13 (01) : 8 - 13
[7] Efficacy and safety of varenicline, an α4β2 acetylcholine nicotinic receptor partial agonist, for smoking cessation in Japanese smokers
Nakamura, Masakazu
Fujimoto, Yoko
Maruyama, Nami
Ishibashi, Taro
Reeves, Karen
[J]. CIRCULATION, 2006, 114 (18) : 856 - 856
[8] Efficacy and safety of the novel selective nicotinic receptor partial agonist varenicline for smoking cessation
Oncken, C
Watsky, E
Reeves, K
Anziano, R
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 381A - 381A
[9] Smoking cessation efficacy and safety of varenicline, an α4β2 nicotinic receptor partial agonist
Tonstad, Serena
[J]. JOURNAL OF CARDIOVASCULAR NURSING, 2006, 21 (06) : 433 - 436
[10] The efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation in Taiwanese and Korean smokers
Kim, Dac-Hyun
Tsai, Shih-Tzu
Cho, Hong-Jun
Chang, Wen-Dau
Kim, Cheol-Hwan
Cheng, Huey-Shinn
Cho, BeLong
Guo, Fei-Rarl
Paek, Yu-Jin
Hsueh, Kuang-Chieh
Billing, Clare B., Jr.
Williams, Kathryn E.
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 82 - 82

← 1 2 3 4 5 →